Evidence map›Paper›PMID 37231394›Full record

ArticleBMC surgery2023

Factors affecting the recurrence of acute cholecystitis after treatment with percutaneous cholecystostomy.

Korhan Tuncer, Gizem Kilinc Tuncer, Bülent Çalık

Open access · goldAbstract read
In one paragraph

Article in BMC surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Cholecystostomy tube management in acute cholecystitis: a population-based cohort study.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Korhan TuncerDepartment of General Surgery, University of Bakırçay, Çiğli Training and Research Hospital, Izmir, Turkey. korhantuncer19@gmail.com.ORCID http://orcid.org/0000-0001-7458-828X
Gizem Kilinc TuncerDepartment of General Surgery, University of Health Sciences Izmir Bozyaka Training and Research Hospital, Izmir, Turkey.ORCID http://orcid.org/0000-0002-6987-3198
Bülent ÇalıkDepartment of General Surgery, University of Health Sciences Izmir Bozyaka Training and Research Hospital, Izmir, Turkey. calikbulentdr@yahoo.com.ORCID http://orcid.org/0000-0002-9054-1446
Izmir University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this study was to determine the recurrence rate of patients who did not have interval cholecystectomy after treatment with percutaneous cholecystostomy and to investigate the factors that may affect the recurrence.

methodsPatients who did not undergo interval cholecystectomy after percutaneous cholecystostomy treatment between 2015 and 2021 were retrospectively screened for recurrence.

results36.3% of the patients had recurrence. Recurrence was found more frequently in patients with fever symptoms at the time of admission to the emergency department (p = 0.003). Recurrence was found to be more frequent in those who had a previous cholecystitis attack (p = 0.016). It was determined that patients with high lipase and procalcitonin levels had statistically more frequent attacks (p = 0.043, p = 0.003). It was observed that the duration of catheter insertion was longer in patients who had relapses (p = 0.019). The cut-off value for lipase was calculated as 15.5, and the cut-off value for procalcitonin as 0.955, in order to identify patients at high risk for recurrence. In the multivariate analysis for the development of recurrence, presence of fever, a history of previous cholecystitis attack, lipase value higher than 15.5 and procalcitonin value higher than 0.955 were found to be risk factors.

conclusionsPercutaneous cholecystostomy is an effective treatment method in acute cholecystitis. Insertion of the catheter within the first 24 h may reduce the recurrence rate. Recurrence is more common in the first 3 months following removal of the cholecystostomy catheter. Having a previous history of cholecystitis attack, fever symptom at the time of admission, elevated lipase and procalcitonin are risk factors for recurrence.

Indexed as

CholecystitisCholecystitis, AcuteCholecystostomyHumansProcalcitoninRecurrenceRetrospective StudiesTreatment OutcomeProcalcitoninAcute cholecystitisCalculous cholecystitisPercutaneous cholecystostomyRecurrenceTokyo guidelines

Identifiers

PMID37231394
PMCPMC10214586
OpenAlexW4378212494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.